Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Equity: 2022-2024

Historic Return on Equity for Kiniksa Pharmaceuticals International (KNSA) over the last 3 years, with Dec 2024 value amounting to -0.10%.

  • Kiniksa Pharmaceuticals International's Return on Equity rose 26.00% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 26.00%. This contributed to the annual value of -0.10% for FY2024, which is 5.00% up from last year.
  • Kiniksa Pharmaceuticals International's Return on Equity amounted to -0.10% in FY2024, which was up 31.93% from -0.14% recorded in FY2023.
  • Kiniksa Pharmaceuticals International's 5-year Return on Equity high stood at 0.92% for FY2022, and its period low was -0.14% during FY2023.
  • Its 3-year average for Return on Equity is 0.23%, with a median of -0.10% in 2024.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by 106bps in 2023, then increased by 5bps in 2024.
  • Kiniksa Pharmaceuticals International's Return on Equity (Yearly) stood at 0.92% in 2022, then slumped by 106bps to -0.14% in 2023, then grew by 5bps to -0.10% in 2024.